A Double-blind, Placebo-controlled, Randomised Study to Investigate the Tolerability, Safety and Pharmacokinetics of Oral Multiple Ascending Doses of AZD1236 in Healthy Young Subjects and of an Oral Single Dose of AZD1236 in Healthy Elderly Subjects
Study identifier:D4260C00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Double-blind, Placebo-controlled, Randomised Study to Investigate the Tolerability, Safety and Pharmacokinetics of Oral Multiple Ascending Doses of AZD1236 in Healthy Young Subjects and of an Oral Single Dose of AZD1236 in Healthy Elderly Subjects
Medical condition
Chronic Obstructive Pulmonary Disease
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Sept 2007
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
